Federal and industry sponsors play complementary roles in cancer clinical trials
A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they…
AI-powered blood test detects liver cancer across distinct populations
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer…
Sino Biological launches SuperNuclease® Pro with free trial program
Sino Biological, Inc., a global leader in recombinant technology, announced the launch of SuperNuclease® Pro (Cat#: SSNP02). This…
Lanthanide carriers advance next generation biomedical imaging and theranostics
Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches…
Remdesivir protects kidney and heart health in transplant recipients
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of COVID-19…
Ultrasensitive Blood Test Detects Sjögren’s Disease Years Early, Study Finds
An ultrasensitive blood test could detect Sjögren’s disease more than a decade before a clinical diagnosis, according to…
Hilo aims to make blood pressure a daily habit
Swiss-developed system brings longitudinal blood pressure monitoring to the US, reflecting broader shift toward continuous preventive health. Blood…
AAIC: Blood-Based Alzheimer’s Biomarkers Gain Ground – insights.citeline.com
AAIC: Blood-Based Alzheimer’s Biomarkers Gain Ground insights.citeline.comAlzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the Disease The New…
New battery-powered device detects Bundibugyo Ebola virus in thirty minutes
Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM…
How Medical Devices in Pharmacies Can Save Lives
Medical devices are increasingly being used in-house worldwide, with a global value exceeding US$254 billion. Mexico accounts for…
ABL Diagnostics Announces Renewal of U.S. Patent (US 8,859,198 B2) for Hepatitis B Genotyping and Antiviral Resistance
Reinforcing long-term IP strength in molecular diagnostics and supporting global laboratory partners WOIPPY, FRANCE, June 15, 2026 /EINPresswire.com/…
New DNA test improves diagnosis of rare genetic disorders
A new test provides a much more complete picture of DNA than current standard diagnostics and leads to…